Abstract:Background Human autosomal dominant polycystic kidney disease (ADPKD) is characterized by bilateral renal cysts that lead to a decline in kidney function over time. Previous studies reported aquaporin‐3 (AQP3) expression in cysts derived from collecting ducts in ADPKD. Methods To study the contribution of AQP3 in cyst development, two PKD mouse models, kidney‐specific Pkd1 knockout mice and inducible Pkd1 knockout mice, were generated with or without AQP3 deletion. MDCK cell line was used to study the mechanism in which AQP3 affected cyst development. Results Kidney size and cyst index were significantly smaller in AQP3‐null PKD mice than those in AQP3‐expressing PKD mice, with the difference due mainly to a smaller diameter of collecting duct cysts. AQP3 deficiency inhibits cystogenesis in inducible PKD mice. Importantly, AQP3 deficiency reduced the number of cysts from collecting duct (9.3±1.1 vs. 2.7±0.6) and their diameter. The diameter of AQP3‐MDCK cysts was significantly ~38% larger than in control MDCK cells. The percentage of AQP3‐MDCK cells that formed cysts was significantly lower than in control MDCK cells. AQP3 promoted cyst epithelia cells proliferation. Western‐blot analyses revealed that the expression levels of proliferating cell nuclear antigen (PCNA) in AQP3‐null PKD were reduced as compared with the PKD mice. Consistent with the results in vivo, intracellular ATP in AQP3 null kidney was 75% of that in AQP3‐expressing kidney. We found lower level of AMPK phosphorylation in AQP3‐MDCK cells as compared to MDCK cells. In vivo, the p‐AMPK in AQP3 null kidney was 2.4‐fold more than that in wild‐type kidney. The level of p‐AMPK in PKD mouse kidney was half of which in wild‐type control kidney. AQP3 gene deletion in PKD mice reversed the p‐AMPK level. AQP3 null kidney produced a significant increase in phosphorylated ACC (p‐ACC) levels. We found that S6 phosphorylation in AQP3‐MDCK cells was about 1.6 times as MDCK cells. Western blot revealed that p‐S6 in AQP3 null kidney was 17.7% of that in wild‐type kidney. The level of p‐S6 in PKD mouse kidney was 1.8 fold greater than that in wild‐type mouse kidney. AQP3 gene deletion in PKD mice reversed the p‐S6 to a normal level. The expression of GLUT1 was upregulated and expression of HIF1α was also increased in AQP3‐MDCK cells. These results suggest that AQP3 promotes glucose uptake by increasing GLUT1 expression. Indeed, glucose deprivation abrogated the decrease of p‐AMPK of AQP3‐MDCK cells. Conclusion The experimental results indicate that AQP3 depletion retards cyst growth in part as a consequence of impaired AQP3‐dependent energy metabolism. These findings identify AQP3 as a potential target to reduce cyst development in ADPKD. Support or Funding Information This work was supported by National Natural Science Foundation of China grants 31200869, 81261160507, 81330074 and 81170632, and the 111 Project. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Overexpression of Aquaporin 1 on Cysts of Patients with Polycystic Liver Disease.

Aquaporin‐1 Retards Renal Cyst Development in Polycystic Kidney Disease by Inhibition of Wnt Signaling

Genetics and mechanisms of hepatic cystogenesis

Isolated polycystic liver disease genes define effectors of polycystin-1 function

Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling

A <i>BBS4</i> mutation causes autosomal dominant polycystic liver disease

Expression and Localization of Aquaporin-1 in Human Cirrhotic Liver

Aquaporin‐3 Deficiency Slows Cyst Enlargement in Experimental Mouse Models of Autosomal Dominant Polycystic Kidney Disease

Increased Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Rat Liver after Common Bile Duct Ligation

Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease

Aquaporin 1 is a prognostic marker and inhibits tumour progression through downregulation of Snail expression in intrahepatic cholangiocarcinoma

Expression and regulation of aquaporins in cystic epithelial cells of mice with polycystic kidney disease

Aquaporin‐3 Deficiency Slows Renal Cystogenesis Via Regulation of AMPK/ERK/mTOR Signaling

Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease

Basolateral chloride transporters in autosomal dominant polycystic kidney disease

Expression of aquaporin-2 in ranal cyst epithelial in polycystic kidney disease

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

Aquaporin-3 Deficiency Slows Renal Cyst Growth by Impairment of Glucose Metabolism Via AMPK/ERK/mTOR Signaling

Mosaic PKHD1 in Polycystic Kidneys Caused Aberrant Protein Expression in the Mitochondria and Lysosomes